SCHOTT Pharma AG & Co. KGaA Free Cash Flow Generation Index
SCHOTT Pharma AG & Co. KGaA free cash flow generation index. SCHOTT Pharma AG & Co. KGaA (1SXP) has a Free Cash Flow Generation Index of 0.15x as of September 2024. Free cash flow of €11.29 Million represents 0% of operating cash flow (€75.97 Million). Check 1SXP cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of SCHOTT Pharma AG & Co. KGaA (2020–2024)
Free cash flow generation index of SCHOTT Pharma AG & Co. KGaA from 2020 to 2024. Historical FCF Generation Index trend for SCHOTT Pharma AG & Co. KGaA across 5 annual periods. Explore reinvestment intensity of SCHOTT Pharma AG & Co. KGaA to see what proportion of operating cash flow is directed to capital expenditures.
SCHOTT Pharma AG & Co. KGaA Free Cash Flow Generation Index by Year (2020–2024)
SCHOTT Pharma AG & Co. KGaA free cash flow generation index by year from 2020 to 2024. Year-by-year Free Cash Flow Generation Index for SCHOTT Pharma AG & Co. KGaA. For the full cash flow conversion analysis, see how efficiently does SCHOTT Pharma AG & Co. KGaA generate cash.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.36x | €80.03 Million | €225.33 Million | €145.30 Million | ▲ +952.8% |
| 2023 | 0.03x | €6.13 Million | €181.65 Million | €175.52 Million | ▼ -79.1% |
| 2022 | 0.16x | €29.43 Million | €182.12 Million | €152.69 Million | ▼ -36.4% |
| 2021 | 0.25x | €33.59 Million | €132.21 Million | €98.63 Million | ▲ +38.9% |
| 2020 | 0.18x | €19.09 Million | €104.40 Million | €85.31 Million | — |